In Brief Markow to retire as director of San Antonio Breast Cancer Symposium December 07, 2018Vol.44 No.45
Conversation with The Cancer Letter UAB Cancer Center receives $30 million naming gift from O’Neal Industries December 07, 2018Vol.44 No.45By Paul Goldberg
NCI cuts programs by 5% and non-competing renewals by 3% to maintain paylines in fiscal 2019 December 07, 2018Vol.44 No.45By Matthew Bin Han Ong
Drugs & Targets FDA grants Venclextra accelerated approval for newly-diagnosed AML November 30, 2018Vol.44 No.44
Drugs & Targets FDA approves Daurismo for newly-diagnosed AML in adults 75 years and older November 30, 2018Vol.44 No.44
Drugs & Targets FDA approves gilteritinib for relapsed or refractory AML with a FLT3 mutation November 30, 2018Vol.44 No.44
Drugs & Targets FDA approves Truxima as biosimilar to Rituxan for non-Hodgkin’s lymphoma November 30, 2018Vol.44 No.44
Clinical Roundup Avelumab in platinum-resistant/refractory ovarian cancer did not meet OS and PFS endpoints November 30, 2018Vol.44 No.44
